Profusa, Inc. Common Stock(PFSA)Earnings, Financials & Key Ratios
PFSA•NASDAQ
$0.49
$599214 mkt cap·Price updated May 6, 2026
AboutA digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemiaShow more
- Revenue$0
- EBITDA-$5M+19.9%
- Net Income-$9M+10.2%
- EPS (Diluted)-21.00+9.7%
- Interest Coverage-1.02+28.2%
PFSA Key Insights
Profusa, Inc. Common Stock (PFSA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PFSA Price & Volume
Profusa, Inc. Common Stock (PFSA) stock price & volume — 10-year historical chart
Loading chart...
PFSA Growth Metrics
Profusa, Inc. Common Stock (PFSA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-706.78%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-73.91%
Return on Capital
10 Years-
5 Years-
3 Years-
Last Year-
PFSA Peer Comparison
Profusa, Inc. Common Stock (PFSA) competitors in Medical Devices and Procedure Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 DXCM | 23.29B | 60.36 | 28.88 | 15.6% | 19.31% | 33.83% | 0.51 | |
 ABT | 149.97B | 86.25 | 11.29 | 4.59% | 31.88% | 27.26% | 0.32 | |
 SENS | 221.18M | 5.36 | -3.23 | 56.89% | -196.03% | -113.21% | 0.67 | |
 PODD | 10.61B | 151.17 | 43.44 | 30.73% | 10.44% | 21.38% | 0.69 | |
 TNDM | 1.24B | 18.03 | -5.93 | 7.93% | -20.17% | -141.98% | 2.86 | |
 LIVN | 3.62B | 66.26 | -14.89 | 10.74% | 7.47% | 9.13% | 0.39 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 MASI | 9.35B | 178.49 | -63.74 | -27.1% | 4.9% | 9.08% | 0.78 |
Compare PFSA vs Peers
Profusa, Inc. Common Stock (PFSA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PFSA Income Statement
Profusa, Inc. Common Stock (PFSA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - |
| Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - |
| Operating Expenses | 11.69M | 11.14M | 6.07M | 4.5M | 24.41M |
| OpEx % of Revenue | - | - | - | - | - |
| Selling, General & Admin | 4.77M | 5.24M | 4.08M | 2.99M | 22.29M |
| SG&A % of Revenue | - | - | - | - | - |
| Research & Development | 7.66M | 4.2M | 2.04M | 1.61M | 1.16M |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | -742K | 1.7M | -45K | -100K | 967.08K |
| Operating Income | -11.69M▲ 0% | -11.14M▲ 4.7% | -6.07M▲ 45.5% | -4.5M▲ 25.9% | -24.41M▲ 0% |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | 4.7% | 45.51% | 25.86% | - |
| EBITDA | -10.51M | -10.42M | -6M | -4.81M | -30.6M |
| EBITDA Margin % | - | - | - | - | - |
| EBITDA Growth % | - | 0.89% | 42.42% | 19.87% | -1025.11% |
| D&A (Non-Cash Add-back) | 1.18M | 724K | 0 | 0 | 0 |
| EBIT | -6.23M | -13.95M | -6M | -4.81M | -30.6M |
| Net Interest Income | -4.08M | -6.27M | -4.28M | -4.42M | -2.74M |
| Interest Income | 0 | 0 | 0 | 0 | 106.64K |
| Interest Expense | 4.08M | 6.27M | 4.28M | 4.42M | 2.84M |
| Other Income/Expense | 1.38M | -9.08M | -4.21M | -4.73M | -16.26M |
| Pretax Income | -10.31M▲ 0% | -20.22M▼ 96.1% | -10.28M▲ 49.1% | -9.23M▲ 10.2% | -40.67M▲ 0% |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 18.92K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | -0.05% |
| Net Income | -10.31M▲ 0% | -20.22M▼ 96.1% | -10.28M▲ 49.1% | -9.23M▲ 10.2% | -40.69M▲ 0% |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | - | -96.09% | 49.15% | 10.22% | -706.78% |
| Net Income (Continuing) | -10.31M | -20.22M | -10.28M | -9.23M | -40.69M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -23.25▲ 0% | -46.50▼ 100.0% | -23.25▲ 50.0% | -21.00▲ 9.7% | -96.18▲ 0% |
| EPS Growth % | - | -100% | 50% | 9.68% | -73.91% |
| EPS (Basic) | -23.25 | -46.50 | -23.25 | -21.00 | - |
| Diluted Shares Outstanding | 437.19K | 437.19K | 437.19K | 437.19K | 423.08K |
| Basic Shares Outstanding | 437.19K | 437.19K | 437.19K | 437.19K | 423.08K |
| Dividend Payout Ratio | - | - | - | - | - |
PFSA Balance Sheet
Profusa, Inc. Common Stock (PFSA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Total Current Assets | 958K | 160K | 333K | 260K | 4.2M |
| Cash & Short-Term Investments | 856K | 78K | 142K | 191K | 3.98M |
| Cash Only | 856K | 78K | 142K | 191K | 3.01M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 972K |
| Accounts Receivable | 38K | 0 | 45K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 64K | 82K | 0 | 0 | 0 |
| Total Non-Current Assets | 10.4M | 871K | 1.56M | 2.81M | 55K |
| Property, Plant & Equipment | 10.11M | 0 | 2K | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 9.61M |
| Other Non-Current Assets | 293K | 871K | 1.56M | 2.81M | 3.19M |
| Total Assets | 11.36M▲ 0% | 1.03M▼ 90.9% | 1.89M▲ 83.6% | 3.07M▲ 62.3% | 4.25M▲ 0% |
| Asset Turnover | - | - | - | - | 0.00x |
| Asset Growth % | - | -90.93% | 83.61% | 62.33% | -213.56% |
| Total Current Liabilities | 21.61M | 35.65M | 46.74M | 57.13M | 23.54M |
| Accounts Payable | 3.26M | 3.43M | 3.99M | 4.95M | 6.98M |
| Days Payables Outstanding | - | - | - | - | - |
| Short-Term Debt | 15.01M | 31.03M | 40.4M | 48.21M | 6.71M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 1.3M |
| Other Current Liabilities | 2.42M | 584K | 1.96M | 3.47M | 5.55M |
| Current Ratio | 0.04x | 0.00x | 0.01x | 0.00x | 0.00x |
| Quick Ratio | 0.04x | 0.00x | 0.01x | 0.00x | 0.00x |
| Cash Conversion Cycle | - | - | - | - | - |
| Total Non-Current Liabilities | 73.41M | 65.15M | 65.15M | 65.15M | 14.67M |
| Long-Term Debt | 1.19M | 0 | 0 | 0 | 14.36M |
| Capital Lease Obligations | 7.07M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 65.15M | 65.15M | 65.15M | 65.15M | 73.12M |
| Total Liabilities | 95.02M | 100.8M | 111.89M | 122.28M | 38.21M |
| Total Debt | 24.02M | 31.03M | 40.4M | 48.21M | 21.07M |
| Net Debt | 23.16M | 30.95M | 40.25M | 48.02M | 18.06M |
| Debt / Equity | - | - | - | - | -0.62x |
| Debt / EBITDA | - | - | - | - | -0.69x |
| Net Debt / EBITDA | - | - | - | - | -0.59x |
| Interest Coverage | -2.87x | -1.78x | -1.42x | -1.02x | -10.77x |
| Total Equity | -83.66M▲ 0% | -99.77M▼ 19.3% | -110M▼ 10.2% | -119.2M▼ 8.4% | -33.96M▲ 0% |
| Equity Growth % | - | -19.26% | -10.25% | -8.37% | -5381.71% |
| Book Value per Share | -191.35 | -228.21 | -251.60 | -272.66 | -80.27 |
| Total Shareholders' Equity | -83.66M | -99.77M | -110M | -119.2M | -33.96M |
| Common Stock | 0 | 0 | 0 | 0 | 4K |
| Retained Earnings | -85.23M | -105.45M | -115.73M | -124.96M | -152.21M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
PFSA Cash Flow Statement
Profusa, Inc. Common Stock (PFSA) cash flow — operating, investing & free cash flow history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Cash from Operations | -10.69M | -7.7M | -4.4M | -2.07M | -2.07M |
| Operating CF Margin % | - | - | - | - | - |
| Operating CF Growth % | - | 27.96% | 42.85% | 53.07% | -723.92% |
| Net Income | -10.31M | -20.22M | -10.28M | -9.23M | -40.69M |
| Depreciation & Amortization | 1.18M | 724K | 0 | 0 | 0 |
| Stock-Based Compensation | 72K | 111K | 33K | 21K | 5K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.11M | 10.77M | 4.3M | 4.74M | 22.04M |
| Working Capital Changes | -522K | 909K | 1.54M | 2.41M | 5.42M |
| Change in Receivables | 371K | 38K | -45K | 45K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -60K | 706K | 533K | 645K | 1.06M |
| Cash from Investing | 0 | 0 | -2K | 0 | -7.03M |
| Capital Expenditures | 0 | 0 | -2K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -78.81K |
| Cash from Financing | 8.75M | 6.92M | 4.47M | 2.12M | 21.31M |
| Debt Issued (Net) | 8.7M | 7.7M | 5.06M | 3.08M | 11.41M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 404.56K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 5.92M |
| Other Financing | 51K | -772K | -591K | -961K | 452.53K |
| Net Change in Cash | -1.94M▲ 0% | -778K▲ 59.9% | 64K▲ 108.2% | 49K▼ 23.4% | 2.83M▲ 0% |
| Free Cash Flow | -10.69M▲ 0% | -7.7M▲ 28.0% | -4.4M▲ 42.8% | -2.07M▲ 53.1% | -11.62M▲ 0% |
| FCF Margin % | - | - | - | - | - |
| FCF Growth % | - | 27.96% | 42.82% | 53.09% | -341.13% |
| FCF per Share | -24.45 | -17.62 | -10.07 | -4.73 | -4.73 |
| FCF Conversion (FCF/Net Income) | 1.04x | 0.38x | 0.43x | 0.22x | 0.29x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
PFSA Key Ratios
Profusa, Inc. Common Stock (PFSA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | 89.59% |
| Return on Invested Capital (ROIC) | - | - | - | 77.19% |
| Debt / Equity | - | - | - | -0.62x |
| Interest Coverage | -1.78x | -1.42x | -1.02x | -10.77x |
| FCF Conversion | 0.38x | 0.43x | 0.22x | 0.29x |
PFSA Frequently Asked Questions
Profusa, Inc. Common Stock (PFSA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Profusa, Inc. Common Stock (PFSA) grew revenue by 0.0% over the past year. Growth has been modest.
Profusa, Inc. Common Stock (PFSA) reported a net loss of $40.7M for fiscal year 2024.
Dividend & Returns
Profusa, Inc. Common Stock (PFSA) had negative free cash flow of $11.6M in fiscal year 2024, likely due to heavy capital investments.
Explore More PFSA
Profusa, Inc. Common Stock (PFSA) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates